Europe's MBDA spent 1 billion euros on weapons stocks as Iran crisis adds pressure, CEO says

MBDA has spent €1.0 billion ($1.16 billion) on production without signed contracts to build stocks and keep pace with surging demand, the CEO said. The pre-funded production signals robust underlying demand that could boost future contracts and revenues, but it raises near-term cash and working-capital risk for the company and may affect defense-sector suppliers' short-term liquidity profiles.

Analysis

MBDA has spent €1.0 billion ($1.16 billion) on production without signed contracts to build stocks and keep pace with surging demand, the CEO said. The pre-funded production signals robust underlying demand that could boost future contracts and revenues, but it raises near-term cash and working-capital risk for the company and may affect defense-sector suppliers' short-term liquidity profiles.